|
End-of-day quote
Buenos Aires S.E.
29/09/2026
|
5-day change | 1st Jan Change | ||
| 145.50 ARS | -1.69% |
|
-5.52% | -39.50% |
| Market Cap | 6.2B 4.06M 3.58M 3.39M 3.06M 5.77M 390M 5.84M 40.57M 15.61M 199M 15.26M 14.93M 639M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 6.93B 4.55M 4M 3.79M 3.43M 6.46M 436M 6.54M 45.4M 17.47M 223M 17.08M 16.7M 715M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.69% | ||
| 1 week | -5.52% | ||
| Current month | -10.19% | ||
| 1 month | -10.19% | ||
| 3 months | -11.28% | ||
| 6 months | +7.38% | ||
| Current year | -39.50% |
| 1 week | 143 |  | 150.5 |
| 1 month | 143 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 35 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.69% | -5.52% | +9.81% | +303.61% | 4.06M | |
| -1.50% | +1.71% | +53.43% | +117.47% | 1,056B | |
| -0.48% | -0.90% | +43.86% | +71.93% | 645B | |
| -0.06% | -0.64% | +13.75% | +77.66% | 465B | |
| -1.86% | -0.78% | +75.05% | +43.27% | 368B | |
| -0.06% | -3.88% | +34.32% | +40.74% | 335B | |
| -0.79% | +2.01% | +19.82% | +28.48% | 275B | |
| -1.19% | -1.21% | +9.82% | +12.15% | 255B | |
| -0.13% | +4.37% | +50.19% | +59.16% | 229B | |
| -0.77% | -0.56% | +35.61% | +103.14% | 188B | |
| Average | -0.79% | -0.47% | +34.57% | +85.76% | 381.58B | |
| Weighted average by Cap. | -0.83% | +0.30% | +40.98% | +73.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.43M 4.78M 4.53M 4.09M 7.7M 520M 7.8M 54.17M 20.85M 266M 20.38M 19.93M 853M | 6.4B 4.2M 3.7M 3.5M 3.16M 5.96M 403M 6.04M 41.92M 16.13M 206M 15.77M 15.42M 660M |
| Net income | -1.42B -929K -818K -775K -700K -1.32M -89.12M -1.34M -9.28M -3.57M -45.56M -3.49M -3.41M -146M | -4.6B -3.02M -2.66M -2.52M -2.27M -4.28M -289M -4.34M -30.1M -11.58M -148M -11.32M -11.07M -474M |
| Net Debt | 863M 566K 498K 472K 426K 804K 54.27M 814K 5.65M 2.17M 27.75M 2.13M 2.08M 88.96M | 738M 484K 426K 404K 364K 687K 46.39M 696K 4.83M 1.86M 23.71M 1.82M 1.78M 76.03M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | ARS 145.50 | -1.69% | 11,660 |
| 28/09/26 | ARS 148.00 | +0.68% | 6,385 |
| 25/09/26 | ARS 147.00 | -1.01% | 2,624 |
| 24/09/26 | ARS 148.50 | -3.88% | 3,840 |
| 23/09/26 | ARS 154.50 | +0.32% | 524 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
